Last reviewed · How we verify
NCT07242508
Efficacy of a New Infant Formula Composition on Gut Health in Infants
NA trial testing Infant Formula in Healthy Infants in 120 participants. Not yet recruiting.
19 August 2026
Quick facts
| Lead sponsor | FrieslandCampina |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 120 |
| Start date | 25 November 2025 |
| Primary completion | 19 August 2026 |
| Estimated completion | 19 August 2026 |
Drugs / interventions tested
- Infant Formula — full drug profile →
- Infant Formula with bioactive ingredients
Conditions studied
- Healthy Infants — all drugs for Healthy Infants →
Sponsor
FrieslandCampina — full company profile →
Who can join
Adults 0 Days to 3 Days, any sex, with Healthy Infants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate potential health benefits of the experimental formula. The main objective is whether the experimental formula elevates the relative abundance of Bifidobacterium in stool samples after 10 weeks, as compared a standard formula, aka control formula. In addition other markers of gut health, such as stool characteristics, and gut health symptoms will be monitored
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07242508
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Infant Formula
Trials testing the same drug.
- NCT06475521 — A Randomised, Controlled, Double-blinded, Multi-country, Multi-centre Trial to Study Growth and Health Outcomes of a New · NA · enrolling by invitation
- NCT05947084 — Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas · NA · completed
- NCT05224947 — Gastric Layering and Monitoring II · NA · completed
Other recruiting trials for Healthy Infants
Currently open trials in the same condition.
- NCT07054216 — Probiotic for Infants · NA · recruiting
- NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting
Other FrieslandCampina trials
Trials by the same sponsor.
- NCT06251427 — Assessing the Effectiveness of a Multiple-micronutrient Fortified Maize Pap on the Nutrient Status of Nigerian School-ag · NA · completed
- NCT05813769 — Dairy and Plant Amino Acid Uptake. An Explorative Study · NA · completed
- NCT05670002 — Nutrition Intervention of Complementary Milk Feeding to Improve Linear Growth of at Risk and Stunted Children · NA · completed
- NCT05418491 — The Prolonged Effect of Consumption of a Partially Hydrolyzed Infant Formula During the First 6 Months of Life on the De · completed
- NCT05372601 — Prebiotics and Stress Reduction in Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07242508 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FrieslandCampina
- Last refreshed: 21 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07242508.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing